NCT00269724View on ClinicalTrials.gov

A Study to Evaluate the Safety and Efficacy of OROS® Oxybutynin Chloride for the Treatment of Urge Urinary Incontinence

PHASE3CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

March 31, 1997

Study Completion Date

September 30, 1997

Conditions
Urinary Incontinence
Interventions
DRUG

OROS® oxybutynin

All Listed Sponsors
lead

Alza Corporation, DE, USA

INDUSTRY